United States · FDA National Drug Code directory
Orphenadrine Citrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63629-1564_1a6afbdf-cba9-4ed0-9d82-1f47fb32dd7a
- Product NDC
- 63629-1564
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- ORPHENADRINE CITRATE
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19980619
- Source listing expiry
- 20261231
Source-listed ingredients
- ORPHENADRINE CITRATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 56 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1564-0) · 63629-1564-0
- 20 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1564-1) · 63629-1564-1
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1564-2) · 63629-1564-2
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1564-3) · 63629-1564-3
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1564-4) · 63629-1564-4
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1564-5) · 63629-1564-5
- 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1564-6) · 63629-1564-6
- 45 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1564-7) · 63629-1564-7
- 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1564-8) · 63629-1564-8
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1564-9) · 63629-1564-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →